✦ LIBER ✦

A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus

✍ Scribed by S. K. Thondam; D. J. Cuthbertson; B. S. Aditya; I. A. MacFarlane; J. P. Wilding; C. Daousi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The development of non-peptide glucagon-

✍ Ho-Sang Moon; Mi-Kyung Kim; Moon-Ho Son 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 620 KB

Does glucagon-like peptide-1 receptor ag

✍ Renate E. van Genugten; Daniël H. van Raalte; Michaela Diamant 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 530 KB

Glucagon-like peptide 1 and inhibitors o

✍ Jens Juul Holst; Carolyn F Deacon 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Pharmacological profile of lixisenatide:

✍ Ulrich Werner; Guido Haschke; Andreas W. Herling; Werner Kramer 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 734 KB

Glucagon-Like Peptide-1: The Basis of a

✍ Lotte Bjerre Knudsen 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 10 KB 👁 2 views

Clinical Efficacy and Safety of Once-Wee

✍ Tzefos, M.; Harris, K.; Brackett, A. 📂 Article 📅 2012 🏛 Harvey Whitney Books Company 🌐 English ⚖ 200 KB